[13C6]-Rivaroxaban

Structure only available for Premium member*.

Please log-in/register

* Detail in your account member .

  • Product number: C2139
  • CAS number: 1261392-59-9
  • Molecular formula: C19H18ClN3O5S
  • Molecular weight: 441,84 g.mol-1
  • Min. purity: 98,00 %
  • Min. isotopic enrichment: 99% 13C
  • Solubility: refer to COA
  • Stability: ≥ 1 year
  • Shipping: 24/48h for products in stock
Make a request
Product Number: C2139
Size
Qty

Description

Rivaroxaban is intended for Pharmaceuticals applications. Rivaroxaban is an orally active, direct inhibitor of Factor Xa and a novel antithrombotic agent. All information about [13C6]-Rivaroxaban is provided in the MSDS. We deliver compounds with high purity levels and a comprehensive Certificate of Analysis. Connect to your member account to consult the documents.

Related products

References

  1. Rivaroxaban and apixaban in orthopaedics: is there a difference in their plasma concentrations and anticoagulant effects? Blood Coagulation and Fibrinolysis 2015, 26:925–933
  2. Quantification of direct-acting oral anticoagulants: Application of a clinically validated liquid chromatography-tandem massspectrometry method to forensic cases Drug Test Anal. 2021;13:419–426 [...]
  3. "A UHPLC-MS/MS method to simultaneously quantify apixaban, edoxaban and rivaroxaban in human plasma and breast milk: For emerging lactation studies Journal of Chromatography B Volume 1144, 1 May 2020, 122095" [...]
  4. In vitro assessment of P-gp and BCRP transporter-mediated drug–drug interactions of riociguat with direct oral anticoagulants fundamental & clinical pharmacology, volume 34, issue 1, February 2020, p. 109-119 [...]
  5. Value of quantifying ABC transporters by mass spectrometry and impact on in vitro-to-in vivo prediction of transporter-mediated drug-drug interactions of rivaroxaban European Journal of Pharmaceutics and Biopharmaceutics Volume 148, March 2020, Pages 27-37 [...]
  6. UPLC-MRM Mass Spectrometry Method for Measurement of the Coagulation Inhibitors Dabigatran and Rivaroxaban in Human Plasma and Its Comparison with Functional Assays. PLOS ONE _ December 23, 2015 [...]

Recommendation